1-(2-Methyl-5-nitro-phenyl)-piperidin-4-one → 3-Dimethylaminomethylene-1-(2-methyl-5-nitrophenyl)piperidin-4-one

HRID 2092578

Reaktionsgleichung

Reaktionsgleichung von HRID 2092578
[CH3:1][C:2]1[CH:7]=[CH:6][C:5]([N+:8]([O-:10])=[O:9])=[CH:4][C:3]=1[N:11]1[CH2:16][CH2:15][C:14](=[O:17])[CH2:13][CH2:12]1>COC(OC)N(C)C>[CH3:3][N:11]([CH:16]=[C:13]1[C:14](=[O:17])[CH2:15][CH2:16][N:11]([C:3]2[CH:4]=[C:5]([N+:8]([O-:10])=[O:9])[CH:6]=[CH:7][C:2]=2[CH3:1])[CH2:12]1)[CH3:12]

Komponenten

3

Edukt 1

HCID 666567781-(2-Methyl-5-nitro-phenyl)-piperidin-4-one

Produkt 1

HCID 673288983-Dimethylaminomethylene-1-(2-methyl-5-nitrophenyl)piperidin-4-one

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 78373Dimethylformamide dimethyl acetalLösungsmittel

Versuchsvorschrift

A solution of 1-(2-Methyl-5-nitro-phenyl)-piperidin-4-one [100 mg, 0.426 mmol] in N,N-Dimethylformamide dimethyl acetal (DMA.DMF) [1 ml] was heated to reflux for 12 hrs. After cooling to room temperature, reaction mixture was concentrated under vacuum. The dark brown crude product obtained was further purified by silica gel chromatography using 30-60% ethyl acetate/hexane as eluent to obtain pure desired product i.e., 3-Dimethylaminomethylene-1-(2-methyl-5-nitro-phenyl)-piperidin-4-one [4] as orange solid [Yield: 76.2 mg, 62.02%]

Aufarbeitung

  1. temperatureto reflux for 12 hrs
  2. customreaction mixture
  3. concentrationwas concentrated under vacuum
  4. customThe dark brown crude product obtained
  5. customwas further purified by silica gel chromatography

Quellen und Nachweise

ORD-Eintrag
ord-243105bf2a244b4bbe5c981545d297bf
Quelldatensatz
uspto-grants-2013_05
Patentnummer
US08440679B2

Verknüpfte Notizen

Wird geladen…